This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Zealand Pharma A/S
Drug Names(s): exenatide-gastrin
Description: ZP-3022 is a glucagon-like peptide-1 (GLP-1)-gastrin dual agonist. It is a hybrin peptide consisting of the N terminal portion of exenatide, consisting of 28 amino acids, linked to short gastrin fragment.
Additional information available to subscribers only: